Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2018 3
2019 2
2020 2
2021 3
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Blood-Based Biomarker Panel for Personalized Lung Cancer Risk Assessment.
Fahrmann JF, Marsh T, Irajizad E, Patel N, Murage E, Vykoukal J, Dennison JB, Do KA, Ostrin E, Spitz MR, Lam S, Shete S, Meza R, Tammemägi MC, Feng Z, Hanash SM. Fahrmann JF, et al. J Clin Oncol. 2022 Mar 10;40(8):876-883. doi: 10.1200/JCO.21.01460. Epub 2022 Jan 7. J Clin Oncol. 2022. PMID: 34995129 Free PMC article.
Plasma Based Protein Signatures Associated with Small Cell Lung Cancer.
Fahrmann JF, Katayama H, Irajizad E, Chakraborty A, Kato T, Mao X, Park S, Murage E, Rusling L, Yu CY, Cai Y, Hsiao FC, Dennison JB, Tran H, Ostrin E, Wilson DO, Yuan JM, Vykoukal J, Hanash S. Fahrmann JF, et al. Cancers (Basel). 2021 Aug 6;13(16):3972. doi: 10.3390/cancers13163972. Cancers (Basel). 2021. PMID: 34439128 Free PMC article.
Biomarkers for Lung Cancer Screening and Detection.
Ostrin EJ, Sidransky D, Spira A, Hanash SM. Ostrin EJ, et al. Cancer Epidemiol Biomarkers Prev. 2020 Dec;29(12):2411-2415. doi: 10.1158/1055-9965.EPI-20-0865. Epub 2020 Oct 22. Cancer Epidemiol Biomarkers Prev. 2020. PMID: 33093160 Free PMC article.
Contributions of Circulating microRNAs for Early Detection of Lung Cancer.
Vykoukal J, Fahrmann JF, Patel N, Shimizu M, Ostrin EJ, Dennison JB, Ivan C, Goodman GE, Thornquist MD, Barnett MJ, Feng Z, Calin GA, Hanash SM. Vykoukal J, et al. Cancers (Basel). 2022 Aug 30;14(17):4221. doi: 10.3390/cancers14174221. Cancers (Basel). 2022. PMID: 36077759 Free PMC article.
Assessment of Lung Cancer Risk on the Basis of a Biomarker Panel of Circulating Proteins.
Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Consortium for Early Detection of Lung Cancer; Guida F, Sun N, Bantis LE, Muller DC, Li P, Taguchi A, Dhillon D, Kundnani DL, Patel NJ, Yan Q, Byrnes G, Moons KGM, Tjønneland A, Panico S, Agnoli C, Vineis P, Palli D, Bueno-de-Mesquita B, Peeters PH, Agudo A, Huerta JM, Dorronsoro M, Barranco MR, Ardanaz E, Travis RC, Byrne KS, Boeing H, Steffen A, Kaaks R, Hüsing A, Trichopoulou A, Lagiou P, La Vecchia C, Severi G, Boutron-Ruault MC, Sandanger TM, Weiderpass E, Nøst TH, Tsilidis K, Riboli E, Grankvist K, Johansson M, Goodman GE, Feng Z, Brennan P, Johansson M, Hanash SM. Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Consortium for Early Detection of Lung Cancer, et al. JAMA Oncol. 2018 Oct 1;4(10):e182078. doi: 10.1001/jamaoncol.2018.2078. Epub 2018 Oct 11. JAMA Oncol. 2018. PMID: 30003238 Free PMC article.
14 results